Iovance Biotherapeutics, Inc. - stock earnings
IOVA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -116.4 million USD | 482000 USD |
| 2023Q3 | -113.8 million USD | 469000 USD |
| 2023Q2 | -106.5 million USD | 238000 USD |
| 2023Q1 | -103.9 million USD | ? USD |
| 2022Q4 | -101.9 million USD | ? USD |
| 2022Q3 | -98.8 million USD | ? USD |
| 2022Q2 | -99.0 million USD | ? USD |
| 2022Q1 | -91.5 million USD | ? USD |
| 2021Q4 | -99.3 million USD | ? USD |
| 2021Q3 | -86.1 million USD | ? USD |
| 2021Q2 | -81.4 million USD | ? USD |
| 2021Q1 | -75.4 million USD | ? USD |
| 2020Q4 | -68.4 million USD | ? USD |
| 2020Q3 | -58.6 million USD | 0 USD |
| 2020Q2 | -63.0 million USD | ? USD |
| 2020Q1 | -69.6 million USD | ? USD |
| 2019Q4 | -63.6 million USD | ? USD |
| 2019Q3 | -49.5 million USD | ? USD |
| 2019Q2 | -47.6 million USD | ? USD |
| 2019Q1 | -37.0 million USD | ? USD |
| 2018Q4 | -32.6 million USD | ? USD |
| 2018Q3 | -33.8 million USD | ? USD |
| 2018Q2 | -30.7 million USD | ? USD |
| 2018Q1 | -26.5 million USD | ? USD |
| 2017Q4 | -25.9 million USD | ? USD |
| 2017Q3 | -22.1 million USD | ? USD |
| 2017Q2 | -23.4 million USD | ? USD |
| 2017Q1 | -20.7 million USD | ? USD |
| 2016Q4 | -15.7 million USD | ? USD |
| 2016Q3 | -18.8 million USD | ? USD |
| 2016Q2 | -11.6 million USD | ? USD |
| 2016Q1 | -6.9 million USD | ? USD |
| 2015Q4 | -9.0 million USD | ? USD |
| 2015Q3 | -7.6 million USD | ? USD |
| 2015Q2 | -6.4 million USD | ? USD |
| 2015Q1 | -5.3 million USD | ? USD |
| 2014Q4 | -4.9 million USD | ? USD |
| 2014Q3 | -2.8 million USD | ? USD |
| 2014Q2 | -2.1 million USD | ? USD |
| 2014Q1 | -2.3 million USD | ? USD |
| 2013Q4 | -11.5 million USD | ? USD |
| 2013Q3 | -1.0 million USD | ? USD |
| 2013Q2 | 3.5 million USD | ? USD |
| 2013Q1 | -1.0 million USD | ? USD |
| 2012Q4 | -673896 USD | ? USD |
| 2012Q3 | -673896 USD | ? USD |
| 2012Q2 | -327284 USD | ? USD |
| 2012Q1 | -5.8 million USD | ? USD |
| 2011Q4 | -8.4 million USD | ? USD |
| 2011Q3 | -5.8 million USD | ? USD |
| 2011Q2 | -11.0 million USD | ? USD |
| 2011Q1 | -741922 USD | ? USD |
| 2010Q4 | -741922 USD | ? USD |
| 2010Q3 | -713757 USD | ? USD |
| 2010Q2 | -84629 USD | ? USD |
| 2010Q1 | -67680 USD | ? USD |
| 2009Q4 | -2345 USD | ? USD |
| 2009Q3 | -3470 USD | ? USD |
| 2009Q2 | -3345 USD | ? USD |
| 2009Q1 | -6612 USD | ? USD |
| 2008Q4 | -14338 USD | ? USD |
| 2008Q3 | -2471 USD | ? USD |
| 2008Q2 | -15035 USD | ? USD |
| 2008Q1 | -25296 USD | ? USD |
IOVA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -444.0 million USD | 1.2 million USD |
| 2022 | -389.9 million USD | 238000 USD |
| 2021 | -327.8 million USD | ? USD |
| 2020 | -257.2 million USD | ? USD |
| 2019 | -187.1 million USD | ? USD |
| 2018 | -123.6 million USD | ? USD |
| 2017 | -92.1 million USD | ? USD |
| 2016 | -52.9 million USD | ? USD |
| 2015 | -27.7 million USD | ? USD |
| 2014 | -12.0 million USD | ? USD |
| 2013 | -3.3 million USD | ? USD |
| 2012 | -3.3 million USD | ? USD |
| 2011 | -25.7 million USD | ? USD |
| 2010 | -1.6 million USD | ? USD |
| 2009 | -15772 USD | ? USD |
| 2008 | -57140 USD | ? USD |
IOVA
Price: $12.84
52 week price:
Earnings Per Share: -1.89 USD
P/E Ratio: -3.92
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 3.5 million
Ebitda: -22.1 millionMarket Capitalization: 3.8 billion